Aniara Diagnostica

Aniara Diagnostica is a long-established, family-owned specialty distributor providing critical reagents and tools for coagulation diagnostics and research. Its core business is built on exclusive North American distribution rights for major European manufacturers like HYPHEN BioMed, offering a comprehensive portfolio including anti-Xa assays, DOAC monitoring kits, thrombophilia testing, and specialized research proteins. The company differentiates itself through deep technical expertise in coagulation science, high product quality standards, and a cost-efficient supply chain, positioning it as a key partner for clinical and research laboratories in a complex and regulated diagnostic niche.

Specialized distributor and technical support platform for hemostasis and coagulation diagnostics, built on exclusive partnerships with manufacturers like HYPHEN BioMed. Portfolio includes chromogenic assays (BIOPHEN), clotting assays (HEMOCLOT), DOAC removal products, and purified research reagents.

Competes against large, integrated diagnostics companies like Siemens Healthineers, Werfen (Instrumentation Laboratory), and Stago, which have broad portfolios and direct sales. Aniara differentiates through deep specialization in coagulation, exclusive access to niche products (e.g., the only 510(k)-cleared HIT IgG ELISA in the US), and a strong technical support team focused solely on this field.